Navigation Links
Drug Meant to Heal Turns ‘heel’ and Hars

In a case of a therapeutic drug turning deadly, hundred of persons have been infected with Hepatitis C.//

Chinese officials from the ministry of heath have ordered the recall of samples of the blood-based drug used in the treatment of immune system deficiencies.

The drug manufactured by Guangdong Bioyee Pharmaceutical Co. Ltd., is extracted from human blood and injected intravenously during treatment.

China's Health Ministry and drug watchdog, the State Food and Drug Administration, said that the Guangdong Bioyee Pharmaceutical Co. Ltd. had committed "illegal behavior" in the production of its immunoglobulin drug and that users had tested positive to "Hepatitis C antibodies".

Officials have recalled around 90,000 doses of the drug and ordered the cessation of its production and sale.

Hepatitis C can lead to chronic liver infection and cirrhosis. About 1 percent to 5 percent of people with the disease eventually die from long-term infection, according to the U.S. Centers for Disease Control and Prevention.

The Health News, a newspaper run by China's Health Ministry, quoted experts as saying that the plasma used to make the immunoglobulin drug might have contained either the hepatitis C virus or its antibodies.

It would take two to eight weeks to rule out the chance of hepatitis C infections for the users, the newspaper said.

The reports did not say how many users the drug had affected or how many samples of the drug were problematic.

Doctor Jia Jidong, from Beijing Friendship Hospital, says not everyone with hepatitis C antibodies in their blood have will fall ill with the diseases.

He estimates that about 50 to 85 percent of those tested positive for antibodies will end up contracting the disease and it can take up to eight weeks before symptoms appear.

Fake or tainted drugs have killed dozens in China in recent years and sparked public fury about drug safety.

The Chinese media puts the blame on businesses chasing profits and on complacent official supervision.


ANN
'"/>




Related medicine news :

1. An Enzyme That Turns a One –time Experience into a long-time Memor
2. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
3. Allergy Alarm: Sams Choice Milk Chocolate Turns Bitter with Undisclosed Nuts
4. Where Mothers Skin Turns Into Food For Offspring
5. A Worm Turns: Banking on Blood From a Little Lugworm
6. Toy Story Turns Bitter-Christmas Toys, No Music to the Ears!
7. Leukemia Drug Turns Mini-Molecules Up, Cancer Genes Down
8. Well-known Kerala Actor, Mohanlal, Turns AIDS Activist
9. Fashion Fraternity Turns Socially Conscious
10. Friend’s Love Turns Out to Be Gay Admiratio
11. Super Bug Turns Super Killer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... ... 16, 2017 , ... As New York’s fastest growing ophthalmic ... to their medical staff, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ... division of SightMD. Dr. Giamos will practice primarily out of SightMD’s Riverhead, Southampton, ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... recent partnership with an innovator in the wheelchair accessibility industry, BraunAbility . ... dealer salespeople to sell wheelchair accessible vehicles. With this new incentive plan, BraunAbility ...
(Date:1/16/2017)... CA (PRWEB) , ... January 16, 2017 , ... ... manuscript in the Aesthetic Surgery Journal , the official journal of The ... conducted on lower eyelid retraction surgery. The procedure is designed to correct drooping, ...
(Date:1/16/2017)... ... 16, 2017 , ... San Francisco dentist, Dr. Ben Amini , the ... device which is capable of taking digital impressions of teeth and gums. Conventional bite ... CAD CAM restorations , in terms of speed, efficiency and patient comfort. Increasingly, digital ...
(Date:1/15/2017)... (PRWEB) , ... January 15, 2017 , ... In this ... in the United States for the asthma & allergy friendly mark. This certification program ... independently test and identify consumer products to be more suitable for the 60+ million ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 17, 2017 Catherine ... http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ...      (Logo: ... European Neurological Review , ... Amey reports that despite standard care, temperatures ...
(Date:1/17/2017)... , Jan. 17, 2017  CSSi, the global ... the clinical research industry, will exhibit at the 8 ... Executives (SCOPE 2017), taking place from Tuesday, January 24 ... Miami in Miami, FL. ... proprietary technology platform, SmartStudy™ EMR, which provides a revolutionary ...
(Date:1/17/2017)... York , January 17, 2017 Transparency ... (Cinnamic Acid, Benzoic Acid, Sodium Benzoate, Benzyl Alcohol and Others) Market ... According to the report, the global benzaldehyde derivative market ... to reach US$ 2.14 Bn by 2024, expanding at a CAGR ... ...
Breaking Medicine Technology: